Skip to main content
Premium Trial:

Request an Annual Quote

Quidel Issues $172.5M of Senior Convertible Notes

NEW YORK(GenomeWeb) – Quidel said today in a regulatory document that it is issuing $172.5 million of its senior convertible notes. 

The issuance of the 3.25 percent senior notes due in 2020 is part of a deal between Quidel and the Bank of New York Mellon Trust. The notes will be senior unsecured obligations of Quidel, it said in a document filed with the US Securities and Exchange Commission. 

Quidel announced the public offering of $150 million in convertible senior notes last week. Net proceeds will go toward working capital and other general corporate purposes, which may include acquisitions of products, technologies, or businesses, and share repurchases.

The Scan

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.

Study Explores Animated Digital Message Approach to Communicate Genetic Test Results to Family Members

In the Journal of Genetic Counseling, the approach showed promise in participants presented with a hypothetical scenario related to a familial hereditary breast and ovarian cancer syndrome diagnosis.

Computational Tool Predicts Mammalian Messenger RNA Degradation Rates

A tool called Saluki, trained with mouse and human messenger RNA data, appears to improve mRNA half-life predictions by taking RNA and genetic features into account, a Genome Biology paper reports.

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.